Food News and Research

RSS

Genentech and Biogen Idec submit applications to FDA for Rituxan in chronic lymphocytic leukemia

Genentech, Inc. and Biogen Idec today announced that the companies submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Rituxan (rituximab) plus standard chemotherapy for people with previously untreated or treated chronic lymphocytic leukemia (CLL).

20 May 2009

New vaginal ring designed to prevent sexual transmission of HIV

Researchers from Weill Cornell Medical College have published results showing that a new contraceptive device may also effectively block the transmission of the HIV virus. Findings show that the device prevents infection by the HIV virus in laboratory testing. The promising results are published in the most recent issue of the journal AIDS.

19 May 2009

Salmonella’s weakness for sugar predicts its downfall

For the first time UK scientists have shown what the food poisoning bug Salmonella feeds on to survive as it causes infection: glucose.

19 May 2009

Would eating five portions of fruit and vegetables a day really benefit everyone?

Eating more healthily might be better for us as individuals, but would it be bad news for farmers? A research project funded by the UK Research Councils’ Rural Economy and Land Use Programme had found that if we all followed government advice to eat five portions of fruit and vegetables a day this could have serious implications for the countryside.

19 May 2009

e-mail intervention program helps improve diet and lifestyle

An e-mail intervention program is an effective way to significantly improve diet and physical activity by helping people move more, sit less, and make healthier food choices, according to a Kaiser Permanente Division of Research study in the American Journal of Preventive Medicine.

19 May 2009

A.P. Pharma submits NDA for APF530 in chemo-induced nausea and vomiting

A.P. Pharma, Inc. has announced that it has submitted a New Drug Application (NDA) for its lead product, APF530, to the U.S. Food and Drug Administration (FDA). APF530 is being developed for the prevention of chemotherapy-induced nausea and vomiting (CINV) and is a long-acting formulation of granisetron that utilizes the Company's proprietary Biochronomer drug delivery system.

18 May 2009

New asthma treatment bronchial thermoplasty improves patient quality of life

Chronic asthma sufferers may find new relief in a simple, minimally invasive outpatient procedure known as bronchial thermoplasty, which uses controlled radiofrequency-generated heat to treat the muscles of the airways, preventing them from constricting and narrowing.

18 May 2009

Recession is contributing to a decline in overall family health in the Hispanic community

The economic downturn is contributing to a decline in overall family health in the Hispanic community, with parents prioritizing their children's health over their own. While 44 percent of Hispanics consider it equally important for parents to take care of their own health and the health of their children, significantly more parents say the economic downturn has affected their own health and wellness compared to that of their children (69 percent vs. 59 percent).

18 May 2009

Experts say current recommendations for Vitamin D "grossly inadequate"

Current recommendations for Vitamin D were called "grossly inadequate" today at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress.

18 May 2009

FDA clears new treatment for facial wrinkles

Ellman International, Inc. announced today that the Food and Drug Administration (FDA) has granted clearance to Pelleve, a skin tightening system for the non-ablative treatment of mild to moderate facial wrinkles and rhytids for skin phototypes I-IV.

18 May 2009

Curcumin suppresses fat tissue growth in rodent models

Curcumin, the major polyphenol found in turmeric, appears to reduce weight gain in mice and suppress the growth of fat tissue in mice and cell models.

18 May 2009

Saffron could stop blindness and cure eye disease

Italian scientists say they have found that saffron may hold the key to stopping vision loss as people age and in treating some eye diseases.

17 May 2009

Pregabalin shows potential as treatment for hot flashes

A pill used for nerve pain offers women relief from hot flashes, Mayo Clinic researchers report at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO).

17 May 2009

Combining two chemotherapy drugs with Herceptin shows promise for metastatic HER2+ breast cancer

At the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO), researchers from the Mayo Clinic campus in Florida report that using a combination of capecitabine, vinorelbine, and trastuzumab offers a treatment option that is at least as beneficial as other current options - and doesn't cause hair loss in patients.

17 May 2009

Tobacco control must be elevated as a public health priority

An Essay published this week in the open access journal PLoS Medicine calls for the President Obama to "make a strong public commitment" to tobacco control by mobilizing US Government departments and agencies to achieve a coherent policy after eight years of neglect.

15 May 2009

Stress may indeed be a direct contributor to childhood obesity.

That's according to a new Iowa State University study finding that increased levels of stress in adolescents are associated with a greater likelihood of them being overweight or obese.

15 May 2009

Obese, older and poorer Australians get more chronic diseases

According to researchers at the University of Adelaide, in the past 15 years chronic diseases among older, lower income and obese Australians have increased significantly.

15 May 2009

Swine flu preoccupies world health leaders

It is expected that the upcoming World Health Organisation's (WHO) annual assembly will be dominated this year by the emergence and spread of the new influenza virus H1N1 (swine flu).

14 May 2009

Cimzia approved in U.S. for rheumatoid arthritis

UCB announced today that the U.S. Food and Drug Administration (FDA) approved Cimzia, the only PEGylated anti-TNF (Tumor Necrosis Factor), for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA).

13 May 2009

FDA approves new laser surgery for brain tumors

An MRI-guided laser surgery method, in investigational use at both The Cleveland Clinic and University Hospitals Case Medical Center, holds promise for thousands of brain tumor patients and has earned clearance from the Food and Drug Administration (FDA) for use in neurosurgery.

13 May 2009